Theriva (TOVX) raises ~$4.4M via warrant exercise at $0.54/share; grants 16.2M new warrants

Theriva Biologics, Inc.

Entered warrant inducement with existing holders exercising 8,092,280 shares at $0.54 for ~$4.4M gross proceeds.
Issued new warrants for 16,184,560 shares (200% of exercised) at same $0.54 exercise price, exercisable 5 years from stockholder approval.
Net proceeds will be used for working capital; AGP served as financial advisor with 7% cash fee.
New warrants and underlying shares issued in private placement under Section 4(a)(2); resale registration to be filed within 30 days.
Company must seek stockholder approval for exercise of new warrants; meetings every 60 days if not obtained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.